Shares of Hospira (HSP -1.4%) dip after the company announced a voluntary recall over the...


Shares of Hospira (HSP -1.4%) dip after the company announced a voluntary recall over the weekend of one lot of its Hydromorphone Injection due to two reported complaints of a single Carpuject containing more than the 1 mL labeled fill volume. Pain medications such as Hydromorphone have life-threatening consequences if overdosed.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs